Royalty Pharma PLC (RPRX)

Last Closing Price: 68.67 (2026-11-18)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Royalty Pharma PLC (RPRX) had Revenue of $690.10M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
Revenue
$690.10M
$144.68M
--
$690.10M
$279.27M
$410.84M
$-144.20M
$266.64M
$287.38M
$266.64M
$266.64M
$266.64M
$287.38M
$410.84M
$420.33M
446.03M
557.00M
$0.32
$0.32
Balance Sheet Financials
$1.53B
$16.14B
$17.94B
$19.46B
$1.18B
$7.59B
$8.49B
$9.67B
$9.80B
$8.87B
$9.80B
1.01B
Cash Flow Statement Financials
$2.13B
$-993.25M
$-1.24B
$618.70M
$513.66M
$-105.04M
$333.94M
$-679.22M
--
Fundamental Metrics & Ratios
1.29
--
--
0.44
0.88
100.00%
59.53%
59.53%
--
38.64%
20.96%
$1.15B
--
--
--
0.04
--
19.21
4.69
2.72%
3.01%
1.37%
1.53%
$9.74
$2.07
$3.83